MSG
PJP icon

Main Street Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Main Street Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118 Sell
1
-105
-99% -$11.4K ﹤0.01% 815
2026
Q1 		$11K Buy
+106
New +$11.2K ﹤0.01% 527

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Main Street Group's PJP Position: Q2 2026 in Review

Main Street Group reduced its Invesco Pharmaceuticals ETF (PJP) stake by 99% in Q2 2026, selling an estimated $11.4K and leaving 1 share worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #815.

Main Street Group first reported a position in PJP in Q1 2026 and has held it in 2 quarters since. The position peaked at $11K in Q1 2026. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Main Street Group held 1 share of Invesco Pharmaceuticals ETF worth $118 as of Q2 2026.
  • Main Street Group sold 105 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $11.4K.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #815 holding.
  • Main Street Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
  • Main Street Group's Invesco Pharmaceuticals ETF position peaked at $11K in Q1 2026.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.